☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Regeneron
Regeneron and Sanofi Report the US FDA’s sBLA Acceptance of Dupixent to Treat Chronic Rhinosinusitis with Nasal Polyposis (CRSWNP)
May 13, 2024
Regeneron Reports Results from the P-I/II (CHORD) Study of DB-OTO for Hearing Loss
May 9, 2024
Regeneron Reports the Acceptance of its MAA by the EMA for Linvoseltamab to Treat Multiple Myeloma (MM)
February 5, 2024
Regeneron Reports Positive Results of Odronextamab in P-II (ELM-2) Trial for the Treatment of Follicular Lymphoma
December 12, 2023
Regeneron Reports Two-Year (PULSAR) Trial Results of Eylea HD (aflibercept) for Wet Age-Related Macular Degeneration
October 6, 2023
Regeneron and Sanofi Report the US FDA Acceptance of sBLA for Priority Review of Dupixent to Treat Eosinophilic Esophagitis in Chi...
September 26, 2023
Load more...
Back to Home